---
schema_version: "secwatch.filing_event.v1"
accession: "0001906324-24-000042"
form_type: "8-K"
ticker: "QDEL"
cik: "0001906324"
company_name: "QuidelOrtho Corp"
filed_at: "2024-07-31T23:59:59+00:00"
generated_at: "2026-05-31T14:31:57.338542+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# QuidelOrtho Q2 2024: revenue $637M, GAAP diluted loss ($2.20)/share

## Summary
- Total revenue $637M, down 4% YoY; lower COVID-19 revenue was primary driver.
- GAAP diluted loss per share ($2.20) vs ($0.80) prior year; GAAP operating loss ($118M).
- Adjusted diluted loss per share ($0.07) vs +$0.26; adjusted EBITDA $90M (14% margin).
- Announced $100M annualized cost-savings initiatives to benefit H2 2024 and H1 2025.
- Ex-COVID & U.S. Donor Screening, recurring revenue grew 5% constant currency YoY.

## SEC filing metadata
- accession: 0001906324-24-000042
- form_type: 8-K
- ticker: QDEL
- cik: 0001906324
- company_name: QuidelOrtho Corp
- filed_at: 2024-07-31T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000042/0001906324-24-000042-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000042/qdel-20240731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001906324-24-000042
- JSON: https://secwatch.observer/filing/0001906324-24-000042.json
- Plain text: https://secwatch.observer/filing/0001906324-24-000042.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.